Listen Now

Topics Covered

  • Overview of Breast Cancer
  • New Research Presented at the San Antonio Breast Cancer Symposium (SABCS)
  • Breast Cancer Specific Treatment Updates
  • The Role of Clinical Trials
  • Questions for Our Panel of Experts

Our Panel of Experts

Julie R. Gralow, MD

Professor, Medical Oncology, Jill Bennett Endowed Professorship in Breast Cancer, University of Washington School of Medicine, Director, Breast Medical Oncology, Seattle Cancer Care Alliance

Generosa Grana, MD

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Lisa A. Newman, MD, MPH, FACS

Professor of Surgery, Director, Breast Care Center, University of Michigan Comprehensive Cancer Center; and as of December 1, 2015 – Director of the Breast Oncology Program for the multi-hospital Henry Ford Health System (HFHS) and Founding Medical Director for the HFHS International Center for the Study of Breast Cancer Subtypes

Lisa A. Carey, MD

The Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, Division Chief, Hematology and Oncology, Physician-in-Chief, North Carolina Cancer Hospital, Medical Director, UNC Breast Center, Associate Director for Clinical Research, UNC Lineberger

Lidia Schapira, MD

Associate Professor of Medicine, Harvard Medical School, Staff Oncologist, Massachusetts General Hospital

Kathryn J. Ruddy, MD, MPH

Director, Cancer Survivorship, Department of Oncology, Mayo Clinic

Sarah Kelly, MSW

Older Adult Program Coordinator, CancerCare


You can download the brochure for this workshop(pdf)(144 KB)

Workshop Date

This workshop was originally recorded on January 27, 2016.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top